Log In
BCIQ
Print this Print this
 

MDPK67b

  Manage Alerts
Collapse Summary General Information
Company Med Discovery S.A.
DescriptionRecombinant protease inhibitor targeting human kallikrein-related peptidase 2 (KLK2; hK2)
Molecular Target Kallikrein-related peptidase 2 (KLK2) (hK2)
Mechanism of ActionKallikrein inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationProstate cancer
Indication DetailsTreat prostate cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today